Immunophenotyping of the cerebrospinal fluid as a prognostic factor at diagnosis of acute lymphoblastic leukemia in children and adolescents

References

• Inaba H, Greaves M, Mulligha;n CG. Acute lymphoblastic leukaemia. Lancet. 2013;381(9881):1943–1955.
   PubMed Web of Science ®Google Scholar
• Pui CH, Thiel E. Central nervous system disease in hematological malignances: historical perspective and practical applications. Semin Oncol. 2009;36 (Suppl 2): S2–S16.
   PubMed Web of Science ®Google Scholar
• Hutchison JH, Hardisty RM, Bagshawe KD, et al. Treatment of acute lymphoblastic leukaemia: effect of “prophylactic” therapy against central nervous system leukaemia. Br Med J. 1973;2:381–384.
   Google Scholar
• Simone JV. History of the treatment of childhood ALL: a paradigm for cancer cure. Best Pract Res Clin Haematol. 2006;19(2):353–359.
   PubMed Web of Science ®Google Scholar
• Sayed D, Bradrawy H, Ali AM, Shaker S. Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia. Leuk Res. 2009;33:655–661.
   PubMed Web of Science ®Google Scholar
• Ahluwalia MS, Wallace PK, Peereboom DM. Flow cytometry as a diagnostic tool in lymphomatous or leukemic meningitis. Ready for prime time? Cancer. 2012;118(7):1747–1753.
   Google Scholar
• Crespo-Solis E, López-Karpovitch X, Higuera J, Vega-Ramos B. Diagnosis of acute leukemia in cerebrospinal fluid (CSF-acute leukemia). Curr Oncol Rep. 2012;14:369–378.
   PubMed Web of Science ®Google Scholar
• Galati D, Di Noto R, Del Vecchio L. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies. Leuk Res. 2013;37:231–237.
   PubMed Web of Science ®Google Scholar
• Brandalise SR, Pinheiro VR, Aguiar SS, et al. Benefits of the intermittent use of 6-mercaptopurine and methotrexate in maintenance treatment for low-risk acute lymphoblastic leukemia in children: randomized trial from the Brazilian Childhood Cooperative Group—Protocol ALL-99. J Clin Oncol. 2010;28(11):1911–1918.
   PubMed Web of Science ®Google Scholar
• Quijano S, Lopez A, Sancho JM, et al. Identification of leptomeningeal disease in aggressive B-cell non-Hodgkin's lymphoma: improved sensitivity of flow cytometry. J Clin Oncol. 2009;27 (9):1462–1469.
   PubMed Web of Science ®Google Scholar
• Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med. 1999;18:695–706.
   PubMed Web of Science ®Google Scholar
• Viana MB, Oliveira BM, Cancela CSP. Kaplan-Meier method is inappropriate for estimating cumulative incidence of graft-versus-host disease in the presence of competing events. Am J Hematol. 2010;85(6):458–459.
   PubMed Web of Science ®Google Scholar
  Comment in: Am J Hematol. 2008;83(7):528–530.
   PubMed Web of Science ®Google Scholar
• Finn WG, Peterson LC, James C, Goolsby CL. Enhanced detection of malignant lymphoma in cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol. 1998;110:341–346.
   PubMed Web of Science ®Google Scholar
• French CA, Dorfman DM, Shaheen G, Cibas ES. Diagnosing lymphoproliferative disorders involving the cerebrospinal fluid: increased sensitivity using flow cytometric analysis. Diagn Cytopathol. 2000;23(6):369–374.
   PubMed Web of Science ®Google Scholar
• Subirá D, Castañón S, Román A, et al. Flow cytometry and the study of central nervous disease in patients with acute leukemia. Br J Haematol. 2001;112:381–384.
   PubMed Web of Science ®Google Scholar
• Roma AA, García A, Avagnina A, Rescia C, Elsner B. Lymphoid and myeloid neoplasms involving cerebrospinal fluid: comparison of morphologic examination and immunophenotyping by flow cytometry. Diagn Cytopathol. 2002;27:271–275.
   PubMed Web of Science ®Google Scholar
• Hegde U, Filie A, Little RF, et al. High incidence of occult leptomeningeal disease detected by flow cytometry in newly diagnosed aggressive B-cell lymphomas at risk for central nervous system involvement: the role of flow cytometry versus cytology. Blood. 2005;105(2):496–502.
   PubMed Web of Science ®Google Scholar
• Nückel H, Novotny JR, Noppeney R, Savidou I, Dührsen U. Detection of malignant haematopoietic cells in the cerebrospinal fluid by conventional cytology and flow cytometry. Clin Lab Haem. 2006;28:22–29.
   PubMedGoogle Scholar
• Bromberg JEC, Breems DA, Kraan J, et al. CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies. Neurology. 2007;68:1674–1679.
   PubMed Web of Science ®Google Scholar
• Di Noto R, Scalia G, Abate G, et al. Critical role of multidimensional flow cytometry in detecting occult leptomeningeal disease in newly diagnosed aggressive B-cell lymphomas. Leuk Res. 2008;32:1196–1199.
   PubMed Web of Science ®Google Scholar
• Craig FE, Ohori NP, Gorrill TS, Swerdlow SH. Flow cytometric immunophenotyping of cerebrospinal fluid specimens. Am J Clin Pathol. 2011;135(1):22–34.
   PubMed Web of Science ®Google Scholar
• Alvarez R, Dupuis J, Plonquet A, et al. Clinical relevance of flow cytometric immunophenotyping of the cerebrospinal fluid in patients with diffuse large B-cell lymphoma. Ann Oncol. 2012;23(5):1274–1279.
   PubMed Web of Science ®Google Scholar
• Martinez-Laperche C, Gomez-Garcia AM, Lassaletta A, et al. Detection of occult cerebrospinal fluid involvement during maintenance therapy identifies a group of children with acute lymphoblastic leukemia at high risk for relapse. Am J Hematol. 2013;88:359–364.
   PubMed Web of Science ®Google Scholar
• Liang Y, Ca Q, Zhai ZM, Wang NL. A practical strategy of monitoring minimal residue disease and intervention for central nervous system relapse of childhood acute lymphoblastic leukemia: a single Chinese center's experience. J Pediatr Hematol Oncol. 2013;35(5):388–393.
   PubMed Web of Science ®Google Scholar
• Ranta S, Nilsson F, Harila-Saari A, et al. Detection of central nervous system involvement in childhood acute lymphoblastic leukemia by cytomorphology and flow cytometry of the cerebrospinal fluid. Pediatr Blood Cancer. 2015;62:951–956.
   PubMed Web of Science ®Google Scholar
• Brem SS, Black P, Brem H, et al. NCCN clinical practice guidelines in oncology. Central nervous system cancers. J Natl Compr Cancer Netw. 2008;6(5):456–504.
   Google Scholar
• Schinstine M, Filie AC, Wilson W, Stetler-Stevenson M, Abati A. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious. Cancer (Cancer Cytopathol). 2006;108(3):157–162.
   PubMed Web of Science ®Google Scholar
• Cancela CSP, Murao M, Souza MEL, et al. Central nervous system involvement in acute lymphoblastic leukemia: diagnosis by immunophenotyping. J Bras Patol Med Lab. 2013;49(4):260–263.
   Google Scholar
• Bürger B, Zimmermann M, Mann G, et al. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture. J Clin Oncol. 2003;21:184–188.
   PubMed Web of Science ®Google Scholar
• Gajjar A, Harrison PL, Sandlund JT, et al. Traumatic lumbar puncture at diagnosis adversely affects outcome in 146 American Society of Hematology childhood acute lymphoblastic leukemia. Blood. 2000;96:3381–3384.
   PubMed Web of Science ®Google Scholar
• Rech A, Carvalho GP, Meneses CF, Hankins J, Howard S, Brunetto AL. The influence of traumatic lumbar puncture and timing of intrathecal therapy on outcome of pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2005;22:483–488.
   PubMed Web of Science ®Google Scholar
• Te Loo DM, Kamps WA, van der Does-van den Berg A, van Wering ER, Graaf SSN. Prognostic significance of blasts in the cerebrospinal fluid without pleiocytosis or a traumatic lumbar puncture in children with acute lymphoblastic leukemia: experience of the Dutch Childhood Oncology Group. J Clin Oncol. 2006;24(15):2332–2336.
   PubMed Web of Science ®Google Scholar
• Shaikh F, Voicu L, Tole S, et al. The risk of traumatic lumbar punctures in children with acute lymphoblastic leukaemia. Eur J Cancer. 2014;50(8):1482–1489.
   PubMed Web of Science ®Google Scholar
• Pui CH. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematol Am Soc Hematol Educ Program. 2006:142–146.
   PubMedGoogle Scholar
• Jastaniah W, Elimam N, Abdalla K, Khattab TM, Felimban S, Abrar MB. Does the early intensification of intrathecal therapy improve outcomes in pediatric acute lymphoblastic leukemia patients with CNS2/TLP+ status at diagnosis? Hematology. 2015;20(10):561–566.
   Google Scholar
• Hasegawa D, Manabe A, Ohara A, et al. The utility of performing the initial lumbar puncture on day 8 in remission induction therapy for childhood acute lymphoblastic leukemia: TCCSG L99–15 study. Pediatr Blood Cancer. 2012;58:23–30.
   PubMed Web of Science ®Google Scholar